GHRP-6
About
About GHRP-6
GHRP-6 is a first-generation growth hormone-releasing peptide that produces potent GH release but is associated with significant appetite stimulation due to its ghrelin-like activity. It has been largely replaced by cleaner secretagogues like ipamorelin in clinical practice. Research also highlights anti-inflammatory and cytoprotective effects. It is available as a compounded peptide.
Science
Mechanism of Action
Acts as a ghrelin mimetic at GHSR-1a receptors, stimulating GH release while also activating central appetite pathways — accounting for its hunger-stimulating side effect profile.
Dosing
Typical Protocol
100–300 mcg subcutaneous injection 2–3x daily; appetite stimulation is a common and expected side effect.
⚠ Protocol information is for educational purposes only. Dosing must be determined by a licensed physician based on individual health status and goals.
Regulatory
Legal Status in 2026
This compound occupies a regulatory grey area in 2026. It is neither explicitly FDA-approved nor clearly illegal for personal use, but it lacks formal clinical approval and may not be legally sold for human use in all contexts. Proceed with caution: source quality is variable, and regulatory status can change. Always consult a physician.
Evidence
Evidence Tier
Evidence primarily from animal studies, cell cultures, or small pilot human trials. Results are promising but have not yet been confirmed in large-scale human RCTs. Effects in humans may differ from animal models.
Find a Verified Provider
See which Vial-verified providers offer GHRP-6 — with trust scores, legal credentials, and pricing transparency.